Archive - March 2018
Moderna’s vaccines head steps down as multiple programs undergo phase 1: report
Many clinical trial status discrepancies identified between ClinicalTrials.gov and EUCTR
BI, Lilly expand Jardiance programme in heart failure
BMS’ Opdivo cleared for monthly use
Gedeon’s re-filed Neulasta biosimilar under EU review
PHE campaign calls on the UK to diet
White House proposes reviving CSRs—if conservative policies are attached
Rucker: Interoperability depends on open APIs